131 related articles for article (PubMed ID: 7624640)
1. Interstitial brachytherapy versus cytoreductive surgery in recurrent malignant glioma.
Ryken TC; Hitchon PW; VanGilder JC; Wen BC; Jani S
Stereotact Funct Neurosurg; 1994; 63(1-4):241-5. PubMed ID: 7624640
[TBL] [Abstract][Full Text] [Related]
2. Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas.
Wang C; Liu S; Peng L; Zhang K; Li W; Zhang H; Luan Y; Li P; Hu X
BMC Cancer; 2020 Jun; 20(1):591. PubMed ID: 32580723
[TBL] [Abstract][Full Text] [Related]
3. Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas.
Zamorano L; Li Q; Tekyi-Mensah S; Gaspar L; Fontanesi J; Levin K
Stereotact Funct Neurosurg; 2003; 81(1-4):10-7. PubMed ID: 14742958
[TBL] [Abstract][Full Text] [Related]
4. Survival following interstitial brachytherapy for recurrent malignant glioma.
Kitchen ND; Hughes SW; Taub NA; Sofat A; Beaney RP; Thomas DG
J Neurooncol; 1994; 18(1):33-9. PubMed ID: 8057132
[TBL] [Abstract][Full Text] [Related]
5. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.
Gabayan AJ; Green SB; Sanan A; Jenrette J; Schultz C; Papagikos M; Tatter SP; Patel A; Amin P; Lustig R; Bastin KT; Watson G; Burri S; Stea B
Neurosurgery; 2006 Apr; 58(4):701-9; discussion 701-9. PubMed ID: 16575334
[TBL] [Abstract][Full Text] [Related]
6. High activity iodine-125 interstitial implant for gliomas.
Scharfen CO; Sneed PK; Wara WM; Larson DA; Phillips TL; Prados MD; Weaver KA; Malec M; Acord P; Lamborn KR
Int J Radiat Oncol Biol Phys; 1992; 24(4):583-91. PubMed ID: 1429079
[TBL] [Abstract][Full Text] [Related]
7. Brachytherapy for recurrent malignant astrocytoma.
Bernstein M; Laperriere N; Glen J; Leung P; Thomason C; Landon AE
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1213-7. PubMed ID: 7961031
[TBL] [Abstract][Full Text] [Related]
8. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.
Tatter SB; Shaw EG; Rosenblum ML; Karvelis KC; Kleinberg L; Weingart J; Olson JJ; Crocker IR; Brem S; Pearlman JL; Fisher JD; Carson K; Grossman SA;
J Neurosurg; 2003 Aug; 99(2):297-303. PubMed ID: 12924704
[TBL] [Abstract][Full Text] [Related]
9. [Iridium 192 brachytherapy of supra-tentorial high grade glioma recurring in irradiated areas: technique and preliminary results of the Pitié-Salpêtrière hospital group].
Boisserie G; Cornu P; Dormont D; Sahel M; Hardiman C; Tep B; Mandin AM; Barret C; Faillot T; Delattre JY; Monjour A; Poisson M; Marsault C; Philippon J; Simon JM; Baillet F; Mazeron JJ
Bull Cancer Radiother; 1996; 83(3):144-52. PubMed ID: 8977564
[TBL] [Abstract][Full Text] [Related]
10. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources.
Gutin PH; Leibel SA; Wara WM; Choucair A; Levin VA; Philips TL; Silver P; Da Silva V; Edwards MS; Davis RL
J Neurosurg; 1987 Dec; 67(6):864-73. PubMed ID: 3316532
[TBL] [Abstract][Full Text] [Related]
11. Interstitial radiation in recurrent malignant gliomas.
Hitchon PW; Jani SK; VanGilder JC; Godersky JC; Doornbos S
Appl Neurophysiol; 1987; 50(1-6):292-4. PubMed ID: 3329866
[TBL] [Abstract][Full Text] [Related]
12. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas.
Leibel SA; Gutin PH; Wara WM; Silver PS; Larson DA; Edwards MS; Lamb SA; Ham B; Weaver KA; Barnett C
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1129-39. PubMed ID: 2557303
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas.
Watson J; Romagna A; Ballhausen H; Niyazi M; Lietke S; Siller S; Belka C; Thon N; Nachbichler SB
Radiat Oncol; 2020 Dec; 15(1):275. PubMed ID: 33298103
[TBL] [Abstract][Full Text] [Related]
14. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
15. Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas.
Schwartz C; Romagna A; Thon N; Niyazi M; Watson J; Belka C; Tonn JC; Kreth FW; Nachbichler SB
Acta Neurochir (Wien); 2015 Oct; 157(10):1757-64; discussion 1764. PubMed ID: 26298594
[TBL] [Abstract][Full Text] [Related]
16. Patterns of relapse in patients with high grade glioma receiving combined treatments including stereotactic re-irradiation for a first relapse.
Antoni D; Jastaniah Z; Haoming QC; Gaultier C; Ahle G; Couchot J; Atlani D; Schott R; Clavier JB; Srour R; Chaussemy D; Noël G
Cancer Radiother; 2016 Jun; 20(4):282-91. PubMed ID: 27318555
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region.
Ruge MI; Kickingereder P; Grau S; Dorn F; Galldiks N; Treuer H; Sturm V
Neuro Oncol; 2013 Dec; 15(12):1721-31. PubMed ID: 24046261
[TBL] [Abstract][Full Text] [Related]
18. Image fusion-guided stereotactic iodine-125 interstitial irradiation of inoperable and recurrent gliomas.
Julow J; Viola Á; Bálint K; Szeifert GT
Prog Neurol Surg; 2007; 20():303-311. PubMed ID: 17317999
[TBL] [Abstract][Full Text] [Related]
19. Treatment of malignant gliomas with interstitial irradiation and hyperthermia.
Stea B; Kittelson J; Cassady JR; Hamilton A; Guthkelch N; Lulu B; Obbens E; Rossman K; Shapiro W; Shetter A
Int J Radiat Oncol Biol Phys; 1992; 24(4):657-67. PubMed ID: 1429088
[TBL] [Abstract][Full Text] [Related]
20. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.
Palmer JD; Siglin J; Yamoah K; Dan T; Champ CE; Bar-Ad V; Werner-Wasik M; Evans JJ; Kim L; Glass J; Farrell C; Andrews DW; Shi W
J Neurooncol; 2015 Sep; 124(2):215-21. PubMed ID: 26024653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
